These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1455 related articles for article (PubMed ID: 18836574)

  • 21. Transient immunosuppression allows transgene expression following readministration of adeno-associated viral vectors.
    Manning WC; Zhou S; Bland MP; Escobedo JA; Dwarki V
    Hum Gene Ther; 1998 Mar; 9(4):477-85. PubMed ID: 9525309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody neutralization poses a barrier to intravitreal adeno-associated viral vector gene delivery to non-human primates.
    Kotterman MA; Yin L; Strazzeri JM; Flannery JG; Merigan WH; Schaffer DV
    Gene Ther; 2015 Feb; 22(2):116-26. PubMed ID: 25503696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel bispecific molecule delivered by recombinant AAV2 suppresses ocular inflammation and choroidal neovascularization.
    Li Y; Zhu P; Verma A; Prasad T; Deng H; Yu D; Li Q
    J Cell Mol Med; 2017 Aug; 21(8):1555-1571. PubMed ID: 28332318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Periocular injection of an adenoviral vector encoding pigment epithelium-derived factor inhibits choroidal neovascularization.
    Gehlbach P; Demetriades AM; Yamamoto S; Deering T; Duh EJ; Yang HS; Cingolani C; Lai H; Wei L; Campochiaro PA
    Gene Ther; 2003 Apr; 10(8):637-46. PubMed ID: 12692592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's disease.
    Janelidze S; Nordström U; Kügler S; Brundin P
    J Gene Med; 2014; 16(9-10):300-8. PubMed ID: 25303717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of lateral spread of transgene expression following subretinal AAV-mediated gene delivery in dogs.
    Bruewer AR; Mowat FM; Bartoe JT; Boye SL; Hauswirth WW; Petersen-Jones SM
    PLoS One; 2013; 8(4):e60218. PubMed ID: 23560080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative Study of Adeno-associated Virus, Adenovirus, Bacu lovirus and Lentivirus Vectors for Gene Therapy of the Eyes.
    Kalesnykas G; Kokki E; Alasaarela L; Lesch HP; Tuulos T; Kinnunen K; Uusitalo H; Airenne K; Yla-Herttuala S
    Curr Gene Ther; 2017; 17(3):235-247. PubMed ID: 28982327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of ocular transduction using single-stranded and self-complementary recombinant adeno-associated virus serotype 2/8.
    Natkunarajah M; Trittibach P; McIntosh J; Duran Y; Barker SE; Smith AJ; Nathwani AC; Ali RR
    Gene Ther; 2008 Mar; 15(6):463-7. PubMed ID: 18004402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of choroidal neovascularization in mice by adeno-associated virus-delivered anti-vascular endothelial growth factor short hairpin RNA.
    Askou AL; Pournaras JA; Pihlmann M; Svalgaard JD; Arsenijevic Y; Kostic C; Bek T; Dagnaes-Hansen F; Mikkelsen JG; Jensen TG; Corydon TJ
    J Gene Med; 2012 Nov; 14(11):632-41. PubMed ID: 23080553
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ocular gene transfer with self-complementary AAV vectors.
    Yokoi K; Kachi S; Zhang HS; Gregory PD; Spratt SK; Samulski RJ; Campochiaro PA
    Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3324-8. PubMed ID: 17591905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ocular Inflammatory Response to Intravitreal Injection of Adeno-Associated Virus Vector: Relative Contribution of Genome and Capsid.
    Timmers AM; Newmark JA; Turunen HT; Farivar T; Liu J; Song C; Ye GJ; Pennock S; Gaskin C; Knop DR; Shearman MS
    Hum Gene Ther; 2020 Jan; 31(1-2):80-89. PubMed ID: 31544533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adeno-associated vector (type 8)-mediated expression of soluble Flt-1 efficiently inhibits neovascularization in a murine choroidal neovascularization model.
    Igarashi T; Miyake K; Masuda I; Takahashi H; Shimada T
    Hum Gene Ther; 2010 May; 21(5):631-7. PubMed ID: 20053138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain.
    Broekman ML; Comer LA; Hyman BT; Sena-Esteves M
    Neuroscience; 2006; 138(2):501-10. PubMed ID: 16414198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secretion of a TNFR:Fc fusion protein following pulmonary administration of pseudotyped adeno-associated virus vectors.
    Sandalon Z; Bruckheimer EM; Lustig KH; Rogers LC; Peluso RW; Burstein H
    J Virol; 2004 Nov; 78(22):12355-65. PubMed ID: 15507622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complement is an essential component of the immune response to adeno-associated virus vectors.
    Zaiss AK; Cotter MJ; White LR; Clark SA; Wong NC; Holers VM; Bartlett JS; Muruve DA
    J Virol; 2008 Mar; 82(6):2727-40. PubMed ID: 18199646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
    Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
    Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improvement of Photoreceptor Targeting via Intravitreal Delivery in Mouse and Human Retina Using Combinatory rAAV2 Capsid Mutant Vectors.
    Reid CA; Ertel KJ; Lipinski DM
    Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6429-6439. PubMed ID: 29260200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SubILM Injection of AAV for Gene Delivery to the Retina.
    Gamlin PD; Alexander JJ; Boye SL; Witherspoon CD; Boye SE
    Methods Mol Biol; 2019; 1950():249-262. PubMed ID: 30783978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct comparison of administration routes for AAV8-mediated ocular gene therapy.
    Igarashi T; Miyake K; Asakawa N; Miyake N; Shimada T; Takahashi H
    Curr Eye Res; 2013 May; 38(5):569-77. PubMed ID: 23489150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of recombinant adeno-associated virus as a gene transfer vector for the retina.
    Grant CA; Ponnazhagan S; Wang XS; Srivastava A; Li T
    Curr Eye Res; 1997 Sep; 16(9):949-56. PubMed ID: 9288458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 73.